{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:52:52Z","timestamp":1778932372482,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.contraception.2004.07.010","type":"journal-article","created":{"date-parts":[[2005,1,6]],"date-time":"2005-01-06T12:15:12Z","timestamp":1105013712000},"page":"1-7","source":"Crossref","is-referenced-by-count":58,"title":["A comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 \u03bcg on premenstrual symptoms"],"prefix":"10.1016","volume":"71","author":[{"given":"Malinee","family":"Sangthawan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surasak","family":"Taneepanichskul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2004.07.010_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/j.1600-0412.2000.079005405.x","article-title":"Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives","volume":"79","author":"Sveindottir","year":"2000","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.contraception.2004.07.010_bib2","first-page":"14","article-title":"A new monophasic oral contraceptive containing drospirenone, effect on premenstrual symptoms","volume":"47","author":"Brown","year":"2002","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.contraception.2004.07.010_bib3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00006842-198607000-00002","article-title":"Perimenstrual symptoms: prevalence and risk factors","volume":"48","author":"Logue","year":"1986","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.contraception.2004.07.010_bib4","first-page":"494","article-title":"Evaluation and management of premenstrual syndrome in clinical psychiatric practice","volume":"49","author":"Osofsky","year":"1988","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.contraception.2004.07.010_bib5","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0002-9378(69)90499-2","article-title":"Typology of menstrual cycle symptoms","volume":"103","author":"Moos","year":"1969","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.contraception.2004.07.010_bib6","series-title":"Menstrual distress questionnaire manual","author":"Moos","year":"1991"},{"key":"10.1016\/j.contraception.2004.07.010_bib7","first-page":"113","article-title":"The premenstrual syndrome, a review","volume":"30","author":"O'Brien","year":"1985","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.contraception.2004.07.010_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/13625189609150670","article-title":"Attitudes to current oral contraceptive use and future developments: the women's perspective","volume":"1","author":"Fuchs","year":"1996","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"10.1016\/j.contraception.2004.07.010_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0010-7824(97)00068-1","article-title":"A longitudinal study of birth control and pregnancy outcome among women in a Swedish population","volume":"56","author":"Larsson","year":"1997","journal-title":"Contraception"},{"issue":"Suppl. 3","key":"10.1016\/j.contraception.2004.07.010_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14730782.2000.12288985","article-title":"Yasmin \u2014 a new oral contraceptive, a new progestogen: the reasons why","volume":"5","author":"Mansour","year":"2000","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"10.1016\/j.contraception.2004.07.010_bib11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9378(98)70047-X","article-title":"Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons","volume":"179","author":"Rosenberg","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.contraception.2004.07.010_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0010-7824(01)00218-9","article-title":"A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation","volume":"64","author":"Sanders","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2004.07.010_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0010-7824(92)90006-F","article-title":"Oral contraceptives in premenstrual syndrome: a randomized comparison of triphasic and monophasic preparations","volume":"46","author":"Backstorm","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2004.07.010_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progestogen","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2004.07.010_bib15","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/00016349509021201","article-title":"Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study","volume":"74","author":"Wang","year":"1995","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.contraception.2004.07.010_bib16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0020-7292(91)90357-B","article-title":"Premenstrual tension: a placebo-controlled efficacy study with spironolactone and medroxyprogesterone acetate","volume":"34","author":"Hellberg","year":"1991","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.contraception.2004.07.010_bib17","first-page":"429","article-title":"Effect of spironolactone on premenstrual syndrome symptoms","volume":"32","author":"Vellacott","year":"1987","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.contraception.2004.07.010_bib18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1749-6632.1995.tb31386.x","article-title":"Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity","volume":"761","author":"Muhn","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.contraception.2004.07.010_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0010-7824(94)00015-O","article-title":"Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity, pharmacological characterization in animal models","volume":"51","author":"Muhn","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2004.07.010_bib20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0010-7824(96)00195-3","article-title":"The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential","volume":"54","author":"Fuhrmann","year":"1996","journal-title":"Contraception"},{"issue":"Suppl. 3","key":"10.1016\/j.contraception.2004.07.010_bib21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/14730782.2000.12288988","article-title":"The acceptability of a novel oral contraceptive containing drospirenone and its effect on well-being","volume":"5","author":"Boschitsch","year":"2000","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"issue":"Suppl.","key":"10.1016\/j.contraception.2004.07.010_bib22","first-page":"985","article-title":"Quality of life issues, potential role for an oral contraception containing ethinyl estradiol and drospirenone","volume":"47","author":"Dickerson","year":"2002","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.contraception.2004.07.010_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0010-7824(00)00083-4","article-title":"An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen","volume":"60","author":"Parsey","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2004.07.010_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/713604397","article-title":"Effect of an oral contraceptive containing drospirenone and ethinyl estradiol on general well-being and fluid-related symptoms","volume":"8","author":"Apter","year":"2003","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"10.1016\/j.contraception.2004.07.010_bib25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1089\/15246090152543148","article-title":"Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder","volume":"10","author":"Freeman","year":"2001","journal-title":"J. Womens Health Gend. Based Med."},{"key":"10.1016\/j.contraception.2004.07.010_bib26","series-title":"Improving access to quality care in family planning. Medical eligibility criteria for contraceptive use methods","year":"1996"},{"key":"10.1016\/j.contraception.2004.07.010_bib27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/13625180008500387","article-title":"A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel","volume":"5","author":"Foidart","year":"2000","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"10.1016\/j.contraception.2004.07.010_bib28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/00003081-199209000-00019","article-title":"Issues in the diagnosis and research of premenstrual syndrome","volume":"35","author":"Mortola","year":"1992","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.contraception.2004.07.010_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1192\/bjp.113.496.265","article-title":"Mood and behavioral changes with progestational agents","volume":"113","author":"Kane","year":"1967","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.contraception.2004.07.010_bib30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0306-4530(94)00063-G","article-title":"Stress, serotonergic function, and mood in user of oral contraceptives","volume":"20","author":"Tuiten","year":"1995","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.contraception.2004.07.010_bib31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0031-9384(97)88991-3","article-title":"The influence of menstrual-cycle phase on the relationship between testosterone and aggression","volume":"62","author":"Dougherty","year":"1997","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.contraception.2004.07.010_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1098-240X(199804)21:2<129::AID-NUR4>3.0.CO;2-L","article-title":"Luteal phase ovarian steroids, stress arousal, premenses perceived stress and premenstrual symptoms","volume":"21","author":"Woods","year":"1998","journal-title":"Res. Nurs. Health"},{"key":"10.1016\/j.contraception.2004.07.010_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0306-4530(92)90058-F","article-title":"Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls","volume":"17","author":"Eriksson","year":"1992","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.contraception.2004.07.010_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1471-0528.1992.tb14507.x","article-title":"Renal sodium retention does not occur during the luteal phase of the menstrual cycle in normal women","volume":"99","author":"Bisson","year":"1992","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.contraception.2004.07.010_bib35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00006842-197303000-00007","article-title":"Correlations between mood, weight, and electrolytes during the menstrual cycle: a renin\u2013angiotensin aldosterone hypothesis of premenstrual tension","volume":"35","author":"Janowsky","year":"1973","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.contraception.2004.07.010_bib36","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/0002-9378(57)90511-2","article-title":"Variations in body weight and salivary sodium in menstrual cycle","volume":"74","author":"Chesley","year":"1957","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.contraception.2004.07.010_bib37","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/bmj.280.6224.1161","article-title":"Progesterone, fluid and electrolytes in premenstrual syndrome","volume":"280","author":"O'Brien","year":"1980","journal-title":"Br. J. Med."},{"key":"10.1016\/j.contraception.2004.07.010_bib38","doi-asserted-by":"crossref","first-page":"564","DOI":"10.7326\/0003-4819-125-7-199610010-00005","article-title":"Relation between sodium balance and menstrual cycle symptoms in normal women","volume":"125","author":"Olson","year":"1996","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.contraception.2004.07.010_bib39","first-page":"79","article-title":"Effect of an oral contraceptive containing ethinyl estradiol and drospirenone on premenstrual symptomatology and health-related quality of life","volume":"48","author":"Borenstein","year":"2003","journal-title":"J. Reprod. Med."}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782404001994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782404001994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T19:47:23Z","timestamp":1705607243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782404001994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0010782404001994"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2004.07.010","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}